Characterization of Low Density Lipoprotein and Mechanism of the Pro Aggregant Effect Through Oxidant Stress and Lipid Exchange
NCT00932087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2010-04-13
Summary
Case control design: lipidomic study in 12 type 2 diabetics with metabolic syndrome, 12 metabolic syndrome without diabetes, 12 subjects with type 1 diabetes and 12 controls
Conditions
- Diabetes
- Metabolic Syndrome
Interventions
- PROCEDURE
-
Blood sample
Blood sample for lipidomic study
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Principal Investigators
-
Philippe MOULIN, MD, PhD · Hospices Civils de Lyon
Eligibility
- Min Age
- 30 Years
- Max Age
- 75 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- France
Study Locations
More Related Trials
-
Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy
NCT03512132 ·Status: RECRUITING
-
Metabolic Syndrome and Prediabetes
NCT07243821 ·Status: RECRUITING
-
Small Dense Low-density Lipoprotein in Patients With Prediabetes and Type 2 Diabetes
NCT01584856 ·Status: UNKNOWN
-
Ischemic Preconditioning and Type 2 Diabetes
NCT03598855 ·Status: COMPLETED ·Phase: NA
-
Progression of Coronary Atherosclerosis in Asymptomatic Diabetic Subjects
NCT02109835 ·Status: UNKNOWN
-
Carotid Atherosclerosis and Vascular Events in People With Diabetes
NCT02929355 ·Status: COMPLETED
-
Search for a Link Between the Different Variables for Glycaemia and Oxidative Stress or Impaired HDL Function
NCT02862860 ·Status: COMPLETED ·Phase: NA
-
Glycation of apoA-I and Diabetic Atherogenesis
NCT05659043 ·Status: UNKNOWN
-
Type 2 Diabetes and Bone Microarchitecture
NCT04765631 ·Status: COMPLETED
-
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.
NCT03010956 ·Status: COMPLETED
-
Study of Cholesterol Levels and Types in African Americans With Type 2 Diabetes
NCT01494298 ·Status: COMPLETED
-
Vascular Function, Fish Protein Hydrolysates and Type 2 Diabetes Mellitus
NCT03318913 ·Status: COMPLETED ·Phase: NA
-
Implication of Metabolic and Genomic Modifications in Elderly Subjects
NCT00951392 ·Status: COMPLETED ·Phase: NA
-
Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention
NCT06682351 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Adavanced Glycated Endproducts and Development of CAD
NCT02089360 ·Status: UNKNOWN
-
PBMC as Biomarkers of Diabetic Cardiomyopathy
NCT05651919 ·Status: RECRUITING
-
Low Density Lipoprotein (LDL) Cholesterol Metabolism in Impaired Glucose Tolerance
NCT01020578 ·Status: COMPLETED
-
Association Between Glycaemic Control and Morbi/Mortality After 5 Years of Follow-up in Type 2 Diabetic Patients
NCT01282060 ·Status: UNKNOWN
-
Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord)
NCT01432509 ·Status: COMPLETED ·Phase: NA
-
Convenient Home Access for Routine Monitoring in Diabetes (Charm-D Study)
NCT06695325 ·Status: RECRUITING
-
the No-reflow in Diabetic Patients Treated With Primary Percutaneous Coronary Intervention (PCI)
NCT04835974 ·Status: UNKNOWN ·Phase: NA
-
Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesteryl Ester Transfer Protein in Type-1 Diabetes Patients
NCT02816099 ·Status: COMPLETED ·Phase: NA
-
Free Fatty Acids and Vascular Function in Subjects With Diabetes
NCT00153179 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease
NCT01422421 ·Status: COMPLETED ·Phase: PHASE4
-
Serum Sphingolipidomic Analyses in Healthy, Diabetic and Prediabetic Subjects
NCT02826759 ·Status: UNKNOWN